Versartis, Inc. (VSAR) Appoints Endocrinologist Bert Bakker, MD, PhD, As Senior Vice President, Medical Affairs
6/23/2014 7:31:44 AM
MENLO PARK, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Versartis, Inc. (Nasdaq:VSAR), an endocrine-focused biopharmaceutical company that is developing VRS-317, a novel, long-acting form of recombinant human growth hormone (rhGH) for the treatment of growth hormone deficiency (GHD), today announced it has added Bert Bakker, MD, PhD, a senior industry executive with expertise in pediatric and adult endocrinology, to its executive team as Senior Vice President, Medical Affairs.
Help employers find you! Check out all the jobs and post your resume.
comments powered by